RLMD Earnings Relmada Therapeutics, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Net income
ROE
Quarterly results
EPS
Net income
ROE
Reported EPS history
1–33 of 33
| Q2 2026 | 2026-06-30 | -0.32 | 2026-08-06 | 10-Q |
| Q1 2026 | 2026-03-31 | -0.22 | 2026-05-12 | 10-Q |
| FY 2025 | 2025-12-31 | -1.45 | 2026-03-19 | 10-K |
| Q3 2025 | 2025-09-30 | -1.16 | 2025-11-13 | 10-Q |
| Q2 2026 | 2025-06-30 | -0.86 | 2026-08-06 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.58 | 2026-05-12 | 10-Q |
| FY 2025 | 2024-12-31 | -2.65 | 2026-03-19 | 10-K |
| Q3 2025 | 2024-09-30 | -2.03 | 2025-11-13 | 10-Q |
| Q2 2025 | 2024-06-30 | -1.31 | 2025-08-07 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.72 | 2025-05-12 | 10-Q |
| FY 2024 | 2023-12-31 | -3.28 | 2025-03-27 | 10-K |
| Q3 2024 | 2023-09-30 | -2.45 | 2024-11-07 | 10-Q |
| Q2 2024 | 2023-06-30 | -1.72 | 2024-08-07 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.87 | 2024-05-08 | 10-Q |
| FY 2023 | 2022-12-31 | -5.30 | 2024-03-19 | 10-K |
| Q3 2023 | 2022-09-30 | -4.04 | 2023-11-08 | 10-Q |
| Q2 2023 | 2022-06-30 | -2.73 | 2023-08-08 | 10-Q |
| FY 2022 | 2021-12-31 | -7.16 | 2023-03-23 | 10-K |
| Q3 2022 | 2021-09-30 | -5.36 | 2022-11-10 | 10-Q |
| Q2 2022 | 2021-06-30 | -2.90 | 2022-08-11 | 10-Q |
| Q2 2019 | 2018-12-31 | -0.55 | 2019-02-13 | 10-Q |
| Q2 2019 | 2017-12-31 | -0.19 | 2019-02-13 | 10-Q |
| Q3 2017 | 2017-03-31 | -0.39 | 2017-05-15 | 10-Q |
| Q2 2018 | 2016-12-31 | -0.22 | 2018-02-12 | 10-Q |
| Q1 2017 | 2016-09-30 | -0.14 | 2016-11-10 | 10-Q |
| Q3 2017 | 2016-03-31 | 0.03 | 2017-05-15 | 10-Q |
| Q2 2017 | 2015-12-31 | 0.19 | 2017-02-10 | 10-Q |
| Q1 2017 | 2015-09-30 | 0.36 | 2016-11-10 | 10-Q |
| Q3 2016 | 2015-03-31 | -2.78 | 2016-05-09 | 10-Q |
| Q2 2016 | 2014-12-31 | -2.66 | 2016-02-05 | 10-Q |
| Q1 2016 | 2014-09-30 | -3.66 | 2015-11-06 | 10-Q |
| Q3 2015 | 2014-03-31 | -0.10 | 2015-05-15 | 10-Q |
| Q2 2015 | 2013-12-31 | -2.74 | 2015-02-13 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.